Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Rowe

Showing results (591-600 of 632) with videos related to

Pageof 64
Sort By:
Clinical Nuclear Medicine|January 24, 2017
Defining the Added Value of 99mTc-MIBI SPECT/CT to Conventional Cross-Sectional Imaging in the Characterization of Enhancing Solid Renal MassesSara Sheikhbahaei, Christopher S Jones, Kristin K Porter, et al.
Medical Oncology (Northwood, London, England)|April 28, 2022
Interim analysis of companion, prospective, phase II, clinical trials assessing the efficacy and safety of multi-modal total eradication therapy in men with synchronous oligometastatic prostate cancerDiane K Reyes, Bruce J Trock, Phuoc T Tran, et al.
Diagnostics (Basel, Switzerland)|November 27, 2021
Whole-Body [<sup>18</sup>F]FDG PET/CT Can Alter Diagnosis in Patients with Suspected Rheumatic DiseaseMatthias Fröhlich, Sebastian Serfling, Takahiro Higuchi, et al.
European Urology|March 19, 2023
Second Version of the Prostate Cancer Molecular Imaging Standardized Evaluation Framework Including Response Evaluation for Clinical Trials (PROMISE V2)Robert Seifert, Louise Emmett, Steven P Rowe, et al.
Oncotarget|July 21, 2016
[64Cu]XYIMSR-06: A dual-motif CAIX ligand for PET imaging of clear cell renal cell carcinomaIl Minn, Soo Min Koo, Hye Soo Lee, et al.
The Journal of Urology|February 26, 2021
A Phase 2/3 Prospective Multicenter Study of the Diagnostic Accuracy of Prostate Specific Membrane Antigen PET/CT with <sup>18</sup>F-DCFPyL in Prostate Cancer Patients (OSPREY)Kenneth J Pienta, Michael A Gorin, Steven P Rowe, et al.
Journal of Imaging Informatics in Medicine|April 8, 2024
An Automated Deep Learning-Based Framework for Uptake Segmentation and Classification on PSMA PET/CT Imaging of Patients with Prostate CancerYang Li, Maliha R Imami, Linmei Zhao, et al.
Angewandte Chemie (International Ed. in English)|October 9, 2012
Sekikaic acid and lobaric acid target a dynamic interface of the coactivator CBP/p300Chinmay Y Majmudar, Jonas W Højfeldt, Carl J Arevang, et al.
Frontiers in Oncology|September 26, 2024
Performance of PSMA-targeted radiotheranostics in an experimental model of renal cell carcinomaRajan Singh, Anand K Thotakura, Suresh Alati, et al.
JCI Insight|January 11, 2022
11C-Para-aminobenzoic acid PET imaging of S. aureus and MRSA infection in preclinical models and humansAlvaro A Ordonez, Matthew Fl Parker, Robert J Miller, et al.
Pageof 64

Showing results (591-600 of 632) with videos related to

Sort By:
Pageof 64
Clinical Nuclear Medicine|January 24, 2017
Defining the Added Value of 99mTc-MIBI SPECT/CT to Conventional Cross-Sectional Imaging in the Characterization of Enhancing Solid Renal MassesSara Sheikhbahaei, Christopher S Jones, Kristin K Porter, et al.
Medical Oncology (Northwood, London, England)|April 28, 2022
Interim analysis of companion, prospective, phase II, clinical trials assessing the efficacy and safety of multi-modal total eradication therapy in men with synchronous oligometastatic prostate cancerDiane K Reyes, Bruce J Trock, Phuoc T Tran, et al.
Diagnostics (Basel, Switzerland)|November 27, 2021
Whole-Body [<sup>18</sup>F]FDG PET/CT Can Alter Diagnosis in Patients with Suspected Rheumatic DiseaseMatthias Fröhlich, Sebastian Serfling, Takahiro Higuchi, et al.
European Urology|March 19, 2023
Second Version of the Prostate Cancer Molecular Imaging Standardized Evaluation Framework Including Response Evaluation for Clinical Trials (PROMISE V2)Robert Seifert, Louise Emmett, Steven P Rowe, et al.
Oncotarget|July 21, 2016
[64Cu]XYIMSR-06: A dual-motif CAIX ligand for PET imaging of clear cell renal cell carcinomaIl Minn, Soo Min Koo, Hye Soo Lee, et al.
The Journal of Urology|February 26, 2021
A Phase 2/3 Prospective Multicenter Study of the Diagnostic Accuracy of Prostate Specific Membrane Antigen PET/CT with <sup>18</sup>F-DCFPyL in Prostate Cancer Patients (OSPREY)Kenneth J Pienta, Michael A Gorin, Steven P Rowe, et al.
Journal of Imaging Informatics in Medicine|April 8, 2024
An Automated Deep Learning-Based Framework for Uptake Segmentation and Classification on PSMA PET/CT Imaging of Patients with Prostate CancerYang Li, Maliha R Imami, Linmei Zhao, et al.
Angewandte Chemie (International Ed. in English)|October 9, 2012
Sekikaic acid and lobaric acid target a dynamic interface of the coactivator CBP/p300Chinmay Y Majmudar, Jonas W Højfeldt, Carl J Arevang, et al.
Frontiers in Oncology|September 26, 2024
Performance of PSMA-targeted radiotheranostics in an experimental model of renal cell carcinomaRajan Singh, Anand K Thotakura, Suresh Alati, et al.
JCI Insight|January 11, 2022
11C-Para-aminobenzoic acid PET imaging of S. aureus and MRSA infection in preclinical models and humansAlvaro A Ordonez, Matthew Fl Parker, Robert J Miller, et al.
Pageof 64